Dako A/S (Acquired by Agilent Technologies, Inc.) And Amgen Expand Collaboration With Plan To Develop New Diagnostic Test
Published: Feb 11, 2014
Glostrup, Denmark, Feb. 11, 2014 (GLOBE NEWSWIRE) -- Dako, an Agilent Technologies company and worldwide provider of cancer diagnostics, today announced a new project with Amgen to develop a molecular diagnostic test using Dako's IQFISH hybridization buffer.
Help employers find you! Check out all the jobs and post your resume.